It’s a sign of just how much attitudes about the patches, and about menopause, have changed. After a report in 2002 suggested that hormone therapy increased the risks of breast cancer and ...
As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is needed for industry-wide adoption.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results